1 Min Read
May 15(Reuters) - Takeda Pharmaceutical Co Ltd
* Says it has entered into an agreement for an absorption-type company split with its wholly-owned subsidiary, SPERA PHARMA, Inc. on May 15
* Says subsidiary was established as a succeeding company on April 20
* Says it plans to transfer a part of Pharmaceutical Sciences businesses of the co to Bushu Pharmaceuticals Ltd.
* Says it will transfer all of the issued shares in succeeding company to Bushu Pharmaceuticals Ltd. based on the share transfer agreement, on July 1
Source text in Japanese: goo.gl/29T46B
Further company coverage: (Beijing Headline News)